Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin

Roch Christian Johnson, Emma Sáez-López, Esaï Sèdjro Anagonou, Godwin Gérard Kpoton, Adjimon Gilbert Ayelo, Ronald Sètondji Gnimavo, Franck Zinsou Mignanwande, Jean-Gabin Houezo, Ghislain Emmanuel Sopoh, Juliet Addo, Lindsay Orford, Georgios Vlasakakis, Nandita Biswas, Felix Calderon, Oscar Della Pasqua, Anna Gine-March, Zaida Herrador, Alfonso Mendoza-Losana, Gabriel Díez, Israel Cruz, Santiago Ramón-García

Open source

DOI
10.1186/s13063-022-06473-9
Published
2022-07-08
Container
Trials
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13063-022-06473-9,
  title = {Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin},
  author = {Roch Christian Johnson and Emma Sáez-López and Esaï Sèdjro Anagonou and Godwin Gérard Kpoton and Adjimon Gilbert Ayelo and Ronald Sètondji Gnimavo and Franck Zinsou Mignanwande and Jean-Gabin Houezo and Ghislain Emmanuel Sopoh and Juliet Addo and Lindsay Orford and Georgios Vlasakakis and Nandita Biswas and Felix Calderon and Oscar Della Pasqua and Anna Gine-March and Zaida Herrador and Alfonso Mendoza-Losana and Gabriel Díez and Israel Cruz and Santiago Ramón-García},
  year = {2022},
  journal = {Trials},
  doi = {10.1186/s13063-022-06473-9},
  url = {https://doi.org/10.1186/s13063-022-06473-9}
}

RIS

TY  - JOUR
TI  - Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin
AU  - Roch Christian Johnson
AU  - Emma Sáez-López
AU  - Esaï Sèdjro Anagonou
AU  - Godwin Gérard Kpoton
AU  - Adjimon Gilbert Ayelo
AU  - Ronald Sètondji Gnimavo
AU  - Franck Zinsou Mignanwande
AU  - Jean-Gabin Houezo
AU  - Ghislain Emmanuel Sopoh
AU  - Juliet Addo
AU  - Lindsay Orford
AU  - Georgios Vlasakakis
AU  - Nandita Biswas
AU  - Felix Calderon
AU  - Oscar Della Pasqua
AU  - Anna Gine-March
AU  - Zaida Herrador
AU  - Alfonso Mendoza-Losana
AU  - Gabriel Díez
AU  - Israel Cruz
AU  - Santiago Ramón-García
PY  - 2022
JO  - Trials
DO  - 10.1186/s13063-022-06473-9
UR  - https://doi.org/10.1186/s13063-022-06473-9
ER  - 

APA

Johnson, R. C., Sáez-López, E., Anagonou, E. S., Kpoton, G. G., Ayelo, A. G., Gnimavo, R. S., Mignanwande, F. Z., Houezo, J., Sopoh, G. E., Addo, J., Orford, L., Vlasakakis, G., Biswas, N., Calderon, F., Pasqua, O. D., Gine-March, A., Herrador, Z., Mendoza-Losana, A., Díez, G., Cruz, I., & Ramón-García, S. (2022). Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin. Trials. https://doi.org/10.1186/s13063-022-06473-9

Source records